SUMMARY To study the possible role of catecholamines in platelet activation, platelet aggregation stimulated by AI?P, collagen, arachidonic acid and l-epinephrine, thromboxane B2 (TXB2) formation and plasma levels of catecholamines and renin were studied in healthy men both before and after 6 days of propranolol treatment (40 mg three times daily) under control conditions and during sympathoadrenergic stimulation by physical exercise (200 W) or smoking. Exercise markedly increased plasma norepinephrine from 128 ± 28 to 998 ± 418 pg/mI (± SD), and plasma renin activity from 1.0 ± 0.5 to 4.2 ± 1.8 ng Al/ ml-hour. Smoking predominantly increased plasma epinephrine, from 47 ± 25 to 154 ± 76 pg/ml. Propranolol did not consistently influence these variables, but blunted the circulatory response to exercise and smoking. Despite the marked increases of plasma catecholamines after both stimuli with and without blockade, platelet aggregation stimulated by ADP, l-epinephrine, collagen and arachidonic acid and associated TXB2 formation were not enhanced. Moreover, as already suggested by a trend toward reduced aggregability in these settings, plasma norepinephrine levels in the same range (745 ± 368 pg/ml) due to infusion (5 ,tg/min) significantly reduced platelet aggregation with low-dose collagen (0.25-0.75 ,ug/ml), 1-epinephrine (0.2-1.0 ,uM) and ADP (0.5-1.5 ,uM). These data do not support a role of endogenous catecholamines in initiating platelet activation and TXB2 formation.
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SMOKING, a well-documented cardiovascular risk factor, and physical effort, which may precipitate myocardial infarction in patients with preexisting coronary artery disease, stimulate catecholamine release.`6 Abnormally reactive platelets may play a role in the development of coronary heart disease and acute myocardial infarction.7 I Several studies have suggested an association between physical stress and platelet activation in coronary artery disease.9 '4 After physical exercise'I 12 and pacing-induced tachycardia in patients with coronary artery disease, 13. 4 24 Propranolol pretreatment blunts the increase of platelet aggregation during tachycardia in coronary patients, 13 and antiplatelet drugs or thrombocytopenia can protect against epinephrine-induced experimental myocardial necrosis. 25 We therefore studied platelet aggregation and thromboxane B2 (TXB2) formation during exercise-or smoking-induced sympathoadrenergic activation both before and after propranolol pretreatment in healthy men. TXB2 formation and platelet aggregation were estimated as described earlier. 26 Briefly, blood was drawn into sodium citrate (3.8%, 1/10 vol/vol) and centrifuged (150-200 g for 5 minutes) at room temperature to prepare platelet-rich plasma (PRP). PRP was adjusted to a platelet count of 250,000/,u with autologous platelet-poor plasma (PPP). Tubes were capped to prevent loss of carbon dioxide. Platelet aggregation was studied by the method of Born27 using a "Labor-Aggregometer" (Fresenius). The percent change of light transmission after addition of aggregating agents was recorded; 100% corresponded to a change of 0. 14 optical density.
The following aggregating agents were tested at fixed times after blood sampling to eliminate time drifts of platelet sensitivity26: Collagen (Horm Chemie), 0.25-10 ,g/ml PRP (50-60 minutes after PLASMA CATECHOLAMINES AND PLATELET FUNCTION/Siess et al.
blood sampling); arachidonic acid, 1.8 mM (at 90 minutes); ADP, 0.5-2.5 pM (at 80-90 minutes); 1-epinephrine, 0.2-5.0 uiM (at 70-80 minutes) (all from Serva). Aggregation-associated thromboxane formation was measured by radioimmunoassay of TXB2, the stable hydrolytic product of TXA2, after acidification and organic solvent extraction of the samples at 5 minutes. A specific TXB2 antiserum (provided by L. Levine, Brandeis University), standard TXB2 (provided by J. Pike, Upjohn Co.), and (3H)-TXB2 (NEN) with a specific activity of 150 Ci/mM, were used. To estimate platelet sensitivity to prostacyclin, PGI2 (provided by J. Pike) was dissolved in a 1:10 solution of 0.1 M TRIS HCl buffer (pH 9.0) and ethanol. From this stock, the test solutions were prepared freshly each day in 0.1 M TRIS HCl buffer (pH 9.0), added to PRP to give final concentrations of 50-2000 pg/ml PRP and preincubated at 37°C for 1 minute. For these studies, aggregation was challenged either with ADP (5 ,uM) or collagen (1 ug/ml PRP).
Plasma catecholamines were determined by a sensitive and specific radioenzymatic assay,28 and plasma renin activity by radioimmunoassay according to Haber et al.29 The data were analyzed using the t test for paired and unpaired values.
Results
Physical exercise markedly increased plasma norepinephrine, whereas cigarette smoking predominantly stimulated plasma epinephrine levels. Systolic blood pressure, heart rate and plasma renin activity were markedly elevated by physical exercise. Smoking increased heart rate only ( fig. 1) . Over the whole range, a close relation (y = 53.5 + 0.0lx; r = 0.66) between plasma norepinephrine and heart rate was found. Propranolol pretreatment lowered basal systolic and diastolic blood pressure as well as heart rate and attenuated the circulatory response to both exercise and smoking and the increase of plasma renin activity after exercise. Basal and stimulated plasma catecholamine levels were not significantly influenced by propranolol ( fig. 1) .
Despite markedly increased endogenous catecholamine levels, platelet aggregation and associated TXB2 formation induced by arachidonic acid, collagen, 1-epinephrine and ADP were not enhanced after either physical exercise or smoking. Platelet sensitivity to prostacyclin was not affected. Both exercise and smoking tended to decrease aggregation with low-dose collagen, ADP and especially l-epinephrine. In addition, propranolol pretreatment, which did not detectably influence platelet aggregation, TXB2 formation or platelet sensitivity to prostacyclin under baseline conditions, seemed to shift back to control levels the reduced platelet aggregability after exercise and smoking ( fig. 2) .
To investigate this weak but consistent trend in more detail, we studied platelet aggregation before and after infusion of norepinephrine, so as to exclude mechanisms other than sympathoadrenergic arousal as mediators of this tendency toward reduced platelet aggregability after exercise or smoking. . t VOL 66, No 1, JULY 1982 8/80 ± 3 to 138 ± 11/91 ± 5 mm Hg (p < 0.01); these changes were similar to those after treadmill exercise. Norepinephrine infusion decreased heart rate from 63 + 9 to 55 + 7 beats/min (p < 0.05), but did not affect plasma epinephrine levels (38 ± 12 vs 44 ± 15 pg/ml).
To test the stability of catecholamines during the platelet studies, aliquots of PRP were split off at several points during aggregation studies in some subjects and at the end (90 minutes after blood sampling) in all, centrifuged to yield PPP, and analyzed for catechola- mines. Norepinephrine, as well as epinephrine, slowly but continuously decreased during processing, reaching -28 ± 5% in control studies and -39 ± 6% after norepinephrine infusion at the end of aggregation studies compared with levels measured immediately after blood sampling. Platelet aggregability was significantly reduced after norepinephrine infusion, especially when induced by l-epinephrine (at all concentrations studied), or by low concentrations of collagen and ADP, whereas aggregation with higher doses of collagen, ADP and arachidonic acid was unchanged (fig. 3) . The mean minimal dose of ADP required for irreversible aggregation was significantly increased, from 1.3 ± 0.24 to 1.71 ± 0.4 ,M (p <0.01).
In two additional experiments, blood samples from resting subjects were split; to one half, exogenous norepinephrine (10 ng/ml) was added, PRP was prepared as usual and aggregation studies were performed in parallel in native and norepinephrine-enriched PRP. Again, aggregability with all stimuli was consistently reduced after norepinephrine addition. This high pharmacologic dose of norepinephrine was virtually 100% carried through the procedure.
Although the platelet count in blood was not significantly altered, the platelet yield in PRP preparations was significantly increased after exercise both before and after propranolol; for aggregation studies, the platelet count in PRP was effectively adjusted (table 1) . Discussion Several facts suggest that catecholamines may affect platelet function: I-epinephrine is a potent aggregating agent in vitro that is antagonized by a-receptor blockers,'8 23 and platelets are endowed with a catecholamine-uptake mechanism30 and atypical a receptors,3' but obviously lack 83 receptors. Some antiplatelet activity has been attributed to propranolol, however, which has been linked to its non-receptormediated membrane-stabilizing properties.24
Although in the present study, physical exercise or smoking markedly increased plasma levels of norepinephrine and epinephrine in healthy men, these catecholamine changes did not detectably enhance platelet aggregation and associated TXB2 formation or blunt platelet sensitivity to prostacyclin. On the contrary, platelets aggregability tended to be reduced after exercise or smoking. In addition, propranolol pretreatment alone in a dosage sufficient to blunt the circulatory responses was without effect on platelet function, but seemed to abolish the reduced sensitivity of platelets. This tendency toward reduced platelet aggregability preexposed to high catecholamine levels could be statistically confirmed in a more detailed experiment in which infusion was used to increase plasma levels of norepinephrine. Thus, catecholamines could be more reliably singled out as the mediator of this reduced aggregability with several stimuli. Based on our data, the mechanisms of reduced platelet response after norepinephrine preexposure cannot be elucidated: Reduced response to l-epinephrine could easily be ex- 36 The marked increase of platelet count in PRP after physical exercise and the lesser increase after smoking can mimick an increase of platelet aggregation and TXB2 formation if platelet counts in PRP are not adjusted. Therefore, platelet counts in PRP must be adjusted before studying aggregation and TXB2 formation.
In several studies in patients with coronary heart disease, signs of platelet activation have been reported after physical exercise or pacing-induced tachycardia."1-'3 For healthy subjects, only few data on the effect of physical exercise on platelet function are available. 11 34 Our data in healthy subjects do not exclude the possibility that in patients with ischemic myocardial disease, in whom plasma levels of catecholamines37 and thromboxane35 are reported to be increased and platelets abnormally reactive,39 exerciseand smoking-induced sympathoadrenergic stimulation may enhance untoward platelet dysfunction at plasma catecholamine levels that have no proaggregatory influence in healthy subjects without endothelial damage. 
